Blog - Page 25 of 37 - Банка за матични клетки

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

As we come to the end of another great Cord Blood Awareness Month, we will be taking a look at just why cord blood banking is so important and what our options are for saving cord blood. Whilst the profile of cord blood banking has increased in recent years, many misconceptions and myths still exist and many people are still unaware of the importance of umbilical cord blood. Here are some key facts:

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will be crucial to achieving this objective.

If you are considering banking your baby’s umbilical cord blood, you may have questioned how long cord blood can be cryogenically stored. In this blog post we answer that frequently asked question.

In 1988, Matt Farrow was just 5 years old and suffering from Fanconi Anaemia. Fanconi anaemia is a complex, genetic medical condition that can affect many body parts and lead to bone marrow failure[1]. He was seriously ill, but when his parents discovered they were expecting a baby who was not only free from the genetic condition but was a perfect match for her brother, the course of medical history was changed.

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

In the past year, potential stem cell uses have rapidly increased and the number of stem cell clinical trials has grown from 6,500 to 7,255. Just in the first half of 2019, there have been impressive developments in regenerative medicine – including a one-year-old boy cured of cancer, and the possibility of a cure for HIV.

Scientists at Duke University, North Carolina have begun investigating the effect of cord blood on sufferers of adult stroke.

100 patients between 18-90 years of age will undergo umbilical cord blood transfusions between 3 and 10 days after their stroke. They will then be monitored for results.

A Canadian study investigating the expansion of umbilical cord blood stem cells has advanced into early clinical trial stages.

The news comes after scientists reported promising initial results, which found that expanded cells could facilitate even faster recoveries than conventional transplants.

Stem Cell Blog

5 ground-breaking clinical trials using cord blood

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

Cord Blood Awareness Month Webinar with Cells4Life

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

Cord Blood Awareness Month: bin it or bank it?

Second HIV patient cured with stem cell treatment

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

Adding 5 Healthy Years: Is It Possible in Our Ageing Population?

How Long Can Cord Blood Be Cryogenically Stored?

If you are considering banking your baby’s umbilical cord blood, you may have questioned how long cord blood can be cryogenically stored. In this blog post we answer that frequently asked question.

A Cure for HIV? New Cord Blood Cancer Trial Announced

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

Summer 2019: An Update On Stem Cell Uses

Umbilical Cord Blood Used to Treat Stroke in Adults

Scientists at Duke University, North Carolina have begun investigating the effect of cord blood on sufferers of adult stroke.

100 patients between 18-90 years of age will undergo umbilical cord blood transfusions between 3 and 10 days after their stroke. They will then be monitored for results.

Making Cord Blood Go Further – Stem Cell Expansion

A Canadian study investigating the expansion of umbilical cord blood stem cells has advanced into early clinical trial stages.

The news comes after scientists reported promising initial results, which found that expanded cells could facilitate even faster recoveries than conventional transplants.

Could Stem Cells Help Treat Ischaemic Stroke Consequences?

Umbilical Cord Stem Cell Therapy for Charcot-Marie-Tooth Disease to Begin Phase 2 Trial

Umbilical Cord Blood Transplant for Lesch-Nyhan Syndrome

World Cord Blood Day 2025

Stem Cell Treatment Could Help Newborns With Brain Damage

Cells4Life Blog Posts

Could Stem Cells Help Treat Ischaemic Stroke Consequences?

Umbilical Cord Stem Cell Therapy for Charcot-Marie-Tooth Disease to Begin Phase 2 Trial

Umbilical Cord Blood Transplant for Lesch-Nyhan Syndrome

World Cord Blood Day 2025

Stem Cell Treatment Could Help Newborns With Brain Damage

Stem Cell Blog

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

If you are considering banking your baby’s umbilical cord blood, you may have questioned how long cord blood can be cryogenically stored. In this blog post we answer that frequently asked question.

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

Scientists at Duke University, North Carolina have begun investigating the effect of cord blood on sufferers of adult stroke.

100 patients between 18-90 years of age will undergo umbilical cord blood transfusions between 3 and 10 days after their stroke. They will then be monitored for results.

A Canadian study investigating the expansion of umbilical cord blood stem cells has advanced into early clinical trial stages.

The news comes after scientists reported promising initial results, which found that expanded cells could facilitate even faster recoveries than conventional transplants.

Cells4Life Blog Posts

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar: